Combined thrombolytic therapy with low-dose recombinant tissue plasminogen activator and urokinase for patients with acute cerebral infarction

医学 溶栓 尿激酶 重组组织纤溶酶原激活剂 脑梗塞 内科学 纤溶酶原激活剂 组织纤溶酶原激活剂 梗塞 外科 麻醉 心肌梗塞 缺血性中风 缺血 改良兰金量表
作者
Guangmin Zhu
出处
期刊:Chinese Journal of Cerebrovascular Diseases
摘要

Objective To observe the efficacy and safety of combined thrombolytic therapy with recombinant tissue plasminogen activator(rt-PA) and urokinase(UK) on patients with acute cerebral infarction.Method Eighty-one patients with acute cerebral infarction(6 hours from onset) were recruited and randomly allocated into four groups:combined thrombolysis group(n=20),rt-PA group(n=22),UK group(n=18),and control group(n=21).The patients in combined thrombolysis group received rt-PA 20 mg and UK 300 000-500 000 IU;the patients in rt-PA group received rt-PA 0.9 mg/kg intravenously;the patients in UK group received UK 10 000-20 000 IU/kg(patients with body weight 75 kg received the same dose of medication as 75 kg),and the maximum dose of UK was 1 500 000 IU;the patients in the control group received to no thrombolytic drugs.The outcome score were evaluated according to the National Institute of Health Stroke Scale(NIHSS) before treatment and four weeks after symptom onset,and to evaluate hemorrhagic transformation,recurrent infarction,and death as the safety indicators.Results ①Before treatment the NIHSS scores in the combined thrombolysis,rt-PA,UK,and control groups were 18.1±3.6,17.9±3.6,18.0±3.4,and 17.3±4.0,respectively,and after treatment they were 9.1±5.6,8.8±5.5,9.6±5.2,and 14.1±4.6,respectively.There were significant differences in each group before and after treatment(P0.01),and also between the 3 thrombolysis groups and the control group(P0.01);but there were no significant differences between each other of the 3 thrombolysis groups.②The total effective rates in the 4 groups but were 85.0%(17/20),86.4%(19/22),83.3%(15/18),and 42.9%(9/21),respectively.As compared between the 3 thrombolysis groups with the control group,there were significant differences(P0.05);and there were no significant differences among the 3 thrombolysis groups(P0.05).③One patient had new attack of cerebral infarction,and 1 patient had hemorrhagic transformation within 24 hours after thrombolytic therapy in the combined thrombolytic group;3 patients had hemorrhagic transformation in the rt-PA group;1 patient had new attack of cerebral infarction in the UK group;2 patients had hemorrhagic transformation,and 1 of them died.One patient had new attack of cerebral infarction,and 1 patient was died in the control group.Conclusion The combined thrombolytic therapy with low-dose rt-PA and UK for the treatment of acute cerebral infarction is safe and effective.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
vicky发布了新的文献求助10
刚刚
默默完成签到 ,获得积分10
1秒前
2秒前
3秒前
xiao发布了新的文献求助10
3秒前
欣喜的梦安完成签到 ,获得积分10
3秒前
斯多姆发布了新的文献求助10
3秒前
Riley完成签到 ,获得积分10
4秒前
4秒前
八戒完成签到,获得积分10
5秒前
牛婷发布了新的文献求助30
6秒前
汉堡包的应助被雪山大地采纳,获得10
7秒前
7秒前
Julyneon发布了新的文献求助10
7秒前
不二子发布了新的文献求助10
8秒前
lina发布了新的文献求助10
8秒前
KKIII发布了新的文献求助10
8秒前
赵健明完成签到,获得积分10
9秒前
微语完成签到,获得积分10
9秒前
香蕉觅云的应助被翩翩起舞采纳,获得30
10秒前
11秒前
舍我其谁发布了新的文献求助10
11秒前
lydia完成签到,获得积分10
11秒前
Maestro_S的应助被司徒南瓜饼采纳,获得10
11秒前
12秒前
丁的发布了新的文献求助10
12秒前
MIMI完成签到,获得积分10
13秒前
13秒前
咕咕咕完成签到,获得积分10
14秒前
14秒前
Maestro_S的应助被凶狠的月饼采纳,获得10
14秒前
14秒前
15秒前
LVZHIPENG发布了新的文献求助10
15秒前
酆老头完成签到,获得积分10
16秒前
Maestro_S的应助被迷人的卿采纳,获得10
17秒前
xiaolaiba完成签到,获得积分10
17秒前
思源的应助被114514采纳,获得10
17秒前
以七发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165074
求助须知:如何正确求助?哪些是违规求助? 9558738
关于积分的说明 21747291
捐赠科研通 7755624
什么是DOI,文献DOI怎么找? 3428780
关于科研通互助平台的介绍 2553162
邀请新用户注册赠送积分活动 2473361